//
AIM2-driven inflammasome activation in heart failure
Rationale and design of the GUIDE-IT study: Guiding Evidence Based Therapy Using Biomarker Intensified Treatment in Heart Failure
Association of Abnormal Left Ventricular Functional Reserve With Outcome in Heart Failure With Preserved Ejection Fraction
The Management of Atrial Fibrillation in Heart Failure: An Expert Panel Consensus
2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society
Longitudinal Change in Galectin-3 and Incident Cardiovascular Outcomes
Cardiac Implantable Electronic Devices in Patients With Left Ventricular Assist Systems
The prevalence and importance of frailty in heart failure with reduced ejection fraction - an analysis of PARADIGM-HF and ATMOSPHERE